LobbyingR1 RCM lobbying by quarter
R1 RCM's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q1 2023; the issues it reports most are Health Issues.
R1 RCM
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $40K | 1 |
| Q2 2023 | $40K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $70K | 1 |
| Q2 2024 | $70K | 1 |
| Q3 2024 | $70K | 1 |
| Q4 2024 | $70K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$660K · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Venable | $660K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Venable | $30K |
| 04/14for Q1 | Venable | $30K |
| 01/05for Q4 2025 | Venable | $30K |
| 25/10/14for Q3 2025 | Venable | $30K |
| 25/07/09for Q2 2025 | Venable | $30K |
| 25/04/11for Q1 2025 | Venable | $30K |
| 25/01/15for Q4 2024 | Venable | $70K |
| 24/10/14for Q3 2024 | Venable | $70K |
| 24/07/18for Q2 2024 | Venable | $70K |
| 24/04/22for Q1 2024 | Venable | $70K |
| 24/01/17for Q4 2023 | Venable | $60K |
| 23/10/20for Q3 2023 | Venable | $60K |
| 23/07/19for Q2 2023 | Venable | $40K |
| 23/04/19for Q1 2023 | Venable | $40K |
| 23/04/14for Q1 2023 | Venable | Under $5,000 |